Faculty of Physical Therapy Cairo University
Cairo, Cairo Governorate, Egypt
Location status: Recruiting
NCT Number: NCT06601569
1. To better understand the factors that contribute to ROM abnormalities in children diagnosed with CP. 2. To describe the distribution of primary (muscle tone and postural stability)and secondary impairments (ROM and functional muscle strength) across the gross motor spectrum measured by GMFCS scores. 3. To evaluate the effects of primary and secondary impairments on gross functional outcome in children with spastic CP. 4. To find any possible correlation between clinical variables.
Interested in participating?
Request Info18 month–5 year
All sexes
Observational
Cairo, Cairo Governorate, Egypt
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Spinal alignment and range of motion measure scale, Modified Ashworth scale (MAS), Early clinical assessment of balance (ECAB) scale, Functional strength assessment scale
Time frame: from 1 august 2024 to 1 october 2024
the aim of the study is to investigate the predicted cause if the range of motion abnormalities measured by (spinal alignment and range of motion assessment scale ) and balance abnormalities ( measured by early clinical assessment of balance scale )in children with cerebral palsy like muscle strength (measured by functional muscle strength scale) and muscle tone changes (measured by modified athwart scale)
Contact information is provided by the study sponsor or research team.
Cairo University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01829724
Brain Damage, Chronic, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06769178
Brain Damage, Chronic, Brain Diseases
Istanbul, Ataşehir, Turkey (Türkiye)
View Trial DetailsNCT07730086
Brain Damage, Chronic, Brain Diseases
Minya, Menia Governorate, Egypt
View Trial DetailsNCT07715006
Brain Damage, Chronic, Brain Diseases
Pittsburgh, Pennsylvania, United States
View Trial Details